cloudyn.png
Wednesday March 3rd, 2021 6:38AM

Vaccine by Nov. 3? Halted study explains just how unlikely

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday.

AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer's illness is a side effect or a coincidence.

“This ought to be reassuring,” NIH Director Dr. Francis Collins said before a Senate committee. “When we say we are going to focus first on safety and make no compromises, here is Exhibit A of how that is happening in practice.”

Scientists have been scrambling to develop a vaccine against the coronavirus since the outbreak began, and the U.S. has launched the world's largest studies — final-stage testing of three leading candidates, with three more trials set to come soon that will each recruit 30,000 test subjects.

Public health experts are worried that President Donald Trump will pressure the Food and Drug Administration to approve a vaccine before it is proven to be safe and effective, a concern senator after senator echoed on Wednesday.

“When it comes to a COVID-19 vaccine, we can’t allow President Trump to repeat his alarming pattern of putting politics ahead of science and public health," said Sen. Patty Murray of Washington, the committee's ranking Democrat.

The U.S. has invested billions of dollars in efforts to quickly develop multiple vaccines against COVID-19. But public fears that a vaccine is unsafe or ineffective could be disastrous, derailing the effort to vaccinate millions of Americans.

Collins said the public needs to understand the process behind telling when any vaccine candidate is ready for widespread use — one that by design is keeping both manufacturers and politicians in the dark until the evidence gels.

About 150 COVID-19 infections in a study of 30,000 people should be enough to tell if that candidate really is working — and an independent group of experts, not the FDA, gets to do the counting.

WHO MONITORS THE STUDIES?

Every vaccine trial is overseen by a “data and safety monitoring board,” or DSMB. These boards include scientists and statisticians who are experts in their fields but have no ties to either the government or the vaccine makers.

The top priority: watching for safety concerns, like the one that sparked a DSMB in Britain to pause AstraZeneca's vaccinations and alert its U.S. counterpart.

But this is the group that also will decide when each vaccine is ready to be evaluated by regulators.

In each 30,000-person study, about half the participants are given the real vaccine and half get dummy shots, and neither they nor their doctors know which is which. Only the DSMB has the power to unlock the code of who got which shot and peek at how the volunteers are faring before a study is finished.

The FDA can't even begin to consider approving a vaccine until the DSMB says the data is good enough for that debate, Collins stressed. Once that happens, the FDA has pledged to bring each candidate before a public vaccine advisory committee.

DOING THE MATH

The FDA already has told manufacturers it won't consider any vaccine that's less than 50% effective.

Say one vaccine trial records that 150 volunteers have gotten sick. The DSMB finds that 100 had received dummy shots and 50 had received the real vaccine. The expert group might decide that’s a promising enough vaccine to stop the study early so that the FDA can debate its merits, even before getting final outcomes from all 30,000 volunteers, said Dr. Larry Corey of the Fred Hutchinson Cancer Research Institute, who is overseeing the U.S. government's vaccine studies.

On the other hand, if equal numbers from the vaccine and placebo groups got infected, the DSMB might declare a vaccine futile, he told The Associated Press. These panels also can calculate infections even before that 150 threshold is met, at set time points in each study.

“If your vaccine is at least 50% effective, you're going to know it because you're going to see a big skewing" of infections, NIH's Collins told the Senate's health, education, labor and pensions committee. “You count those events and you know whether it worked or not.”

ANSWERS UNLIKELY BEFORE THE U.S. ELECTION

Getting the right math before November, as Trump has promised, is “incredibly unlikely,” Corey said.

Collins expressed “cautious optimism” that one of the vaccines being tested will pan out by the end of the year but warned: “Certainly to try to predict whether it happens on a particular week before or after a particular date in early November is well beyond anything that any scientist right now could tell you.”

And even if a study has a spate of infections large enough to prove the effectiveness question, the DSMB also must be comfortable that there's enough evidence of safety before opening the books to the FDA. Generally, the FDA is requiring safety data from at least 3,000 people, Surgeon General Jerome Adams told the Senate panel.

This process isn't new — Phase 3 studies of vaccines and therapies are always done this way, though rarely in so bright a spotlight.

SUSPENDING A STUDY NOT THAT RARE

It’s not uncommon for pauses in research to investigate whether an unexpected health complaint is really related to a vaccine or not, Collins told senators worried about what the AstraZeneca suspension means for the nation's year-end goal.

“The reason we’re investing not in one but six different vaccines is because of the expectation that they won’t all work,” Collins said.

AstraZeneca gave no details on the illness, but Collins said it involved a “spinal cord problem.” Earlier-stage studies hadn't revealed any serious side effects, but that's a key reason for doing ever-larger phases of research — to widen the search for any reactions.

Final testing of two other vaccines is continuing, one created by the NIH and manufactured by Moderna Inc., the other made by Pfizer and Germany's BioNTech. Those two vaccines work differently than AstraZeneca's, which was developed by Oxford University, and the studies already have recruited about two-thirds of the needed volunteers.

Several vaccine candidates made by Chinese companies are in late stages of testing in various countries, but with smaller numbers of volunteers. Most health authorities are skeptical about a claim of vaccine success by Russia, which has test results from just a few dozen people.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Online Headlines - Washington, AP Online Congress News, AP Health, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Emergency fire shelters can save lives, in some conditions
Fourteen firefighters in California had to use emergency fire shelters to survive a destructive blaze, raising questions about how well the shelters work
6:15PM ( 18 minutes ago )
Vaccine by Nov. 3? Halted study explains just how unlikely
The National Institutes of Health director is telling Congress that AstraZeneca's suspension of its COVID-19 vaccine study shows there will be “no compromises” on safety in developing the shots
6:13PM ( 20 minutes ago )
Explosive wildfires across California stoked by fierce winds
Wildfires are raging unchecked across parts of the western United States as winds sweep the region
5:31PM ( 1 hour ago )
U.S. News
Luxury goods giant LVMH cancels $14.5B deal for Tiffany
Luxury goods giant LVMH is ending its monthslong pursuit of jewelry retailer Tiffany & Co. The Paris-based conglomerate said that the French government requested a delay, saying it needs more time to assess the impact of proposed U.S. tariffs
6:26PM ( 7 minutes ago )
'It's how you finish': Serena Williams into Open semifinals
Serena Williams hit 20 aces and came back to beat Tsvetana Pironkova in three sets to get to the U.S. Open semifinals
6:12PM ( 21 minutes ago )
Official claims pressure to alter Homeland Security intel
An official at the Department of Homeland Security says he was pressured by agency leaders to make his intelligence reports reflect the priorities of the Trump administration
6:12PM ( 22 minutes ago )
Associated Press (AP)
Oscars diversity criteria 'not about exclusion' say leaders
The new Oscars best picture inclusion standards became a trending topic on social media as soon as they were announced Tuesday night
5:17PM ( 1 hour ago )
Justice Dept. push into Trump case could prompt dismissal
Attorney General William Barr is defending the Justice Department’s move to intervene in a defamation lawsuit against President Donald Trump
5:12PM ( 1 hour ago )
Book: Trump said of virus, 'I wanted to always play it down'
A new book reveals that President Donald Trump seemed to understand the severity of the coronavirus threat even as he was telling the nation it was no worse than the seasonal flu and insisting the government had it totally under control
4:53PM ( 1 hour ago )
AP National News
No virus aid before election? Pessimism before Senate vote
Top Republicans senators are making pessimistic predictions about securing a bipartisan coronavirus relief package before the November election
5:37PM ( 57 minutes ago )
Woodward defends decision to withhold Trump's virus comments
Bob Woodward, facing widespread criticism for only now revealing President Donald Trump’s early concerns about the severity of the coronavirus, says he needed time to be sure that Trump’s private comments from February were accurate
5:30PM ( 1 hour ago )
Dem report: Postal Service changes delay prescription drugs
Delivery of mail-order prescription drugs was delayed significantly this summer after the new postmaster general ordered major changes in U.S. Postal Service operations
4:41PM ( 1 hour ago )
AP Online Headlines - Washington
McConnell proposes bill to combat doping in horse racing
The Senate’s top Republican and a handful of senior lawmakers in both parties are making a push for legislation to create national standards for the horse racing industry
1:15PM ( 5 hours ago )
The Latest: NIH director: 'No compromises' on safe vaccine
The National Institutes of Health director is telling Congress that AstraZeneca’s suspension of its coronavirus vaccine study shows there will be “no compromises” on safety in developing the shots
1:08PM ( 5 hours ago )
GOP proposes 'targeted' virus aid, but Dems say not enough
Senate Majority Leader Mitch McConnell says the Senate will vote on a trimmed-down Republican coronavirus relief package, though it only has a slim chance of passage in the face of Democrats’ insistence for more sweeping aid
11:06AM ( 7 hours ago )
AP Online Congress News
The Latest: Over 750 Tennessee students, staff test positive
Tennessee reported on Wednesday that 756 students and staff have tested positive for the coronavirus at schools across the state, with more than half the districts reporting
4:59PM ( 1 hour ago )
Stocks bounce back on Wall Street as tech bloodletting halts
Wall Street snapped back Wednesday from its recent tumble, as the bloodletting for big technology stocks came to at least a temporary halt
4:07PM ( 2 hours ago )
UN protection back for threatened Nobel-winning Congo doctor
For weeks, a Nobel Peace Prize-winning Congolese doctor has faced death threats, leading alarmed supporters to urge the United Nations to reinstate the peacekeepers who were withdrawn from his hospital months ago
4:07PM ( 2 hours ago )
AP Business
Fire sweeps refugee camp on Greek island amid virus lockdown
Fire swept through a notoriously overcrowded refugee camp on the Greek island of Lesbos, causing no injuries but leaving thousands in need of emergency shelter
12:39PM ( 5 hours ago )
Jalen Ramsey gets 5-year, $105 million extension from Rams
Jalen Ramsey is becoming the highest-paid defensive back in NFL history after agreeing to a five-year, $105 million contract extension with the Los Angeles Rams
12:06PM ( 6 hours ago )
Former VW boss Winterkorn must stand trial in diesel scandal
Former Volkswagen CEO Martin Winterkorn must face a public trial on fraud charges over the company's diesel emissions scandal from 2015
11:02AM ( 7 hours ago )
AP Business - Corporate News
Stocks perk up on Wall Street as tech bloodletting halts
Wall Street is steadying itself Wednesday following a three-day losing streak, the first in nearly three months
12:34PM ( 6 hours ago )
Strong start for stocks on Wall Street a day after sell-off
Stocks are off to good start on Wall Street, a day after more steep drops in big technology companies pulled indexes sharply lower
9:42AM ( 8 hours ago )
Zimbabwe government announces mining ban in national parks
Zimbabwe’s government says it has banned mining in its national parks, but an environmental group that had taken court action to stop the development of a coal mine in an elephant-rich park said on Wednesday that it will insist on “more than just words.”
8:07AM ( 10 hours ago )
AP Business - Industries
The Latest: Las Vegas children contract inflammatory disease
Health officials said Tuesday that eight Las Vegas-area children under age 14 who tested positive for COVID-19 since March were also diagnosed with a rare inflammatory condition linked with the coronavirus
4:30PM ( 1 day ago )
The Latest: Boston testing lab suspended over virus results
State officials in Massachusetts said a Boston-based coronavirus testing lab that counts dozens of nursing homes among its clients has been suspended by the state after it returned nearly 400 false positive tests
3:43PM ( 1 day ago )
The Latest: Oklahoma female prisoner treated for virus dies
A female Oklahoma state prison inmate treated for coronavirus has died, the Oklahoma Department of Corrections said
3:06PM ( 1 day ago )
AP Business - Health Care
Emergency fire shelters can save lives, in some conditions
Fourteen firefighters in California had to use emergency fire shelters to survive a destructive blaze, raising questions about how well the shelters work
6:15PM ( 21 minutes ago )
Explosive wildfires across California stoked by fierce winds
Wildfires are raging unchecked across parts of the western United States as winds sweep the region
5:31PM ( 1 hour ago )
Big drop reported in vaping by US teenagers
A new federal report shows vaping rates among U.S. teenagers fell dramatically this year, especially among middle school students
5:24PM ( 1 hour ago )
Teacher deaths raise alarms as new school year begins
Teachers in at least three states have died after bouts with the coronavirus since the dawn of the new school year
5:24PM ( 1 hour ago )
Boy's shooting raises questions about police crisis training
An advocacy group says a police shooting that wounded a 13-year-old autistic boy in Salt Lake City reveals shortfalls in the way officers respond to a mental health crisis
5:12PM ( 1 hour ago )